Last reviewed · How we verify
Calciferol — Competitive Intelligence Brief
phase 1
Vitamin D 25-hydroxylase, 25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial, Vitamin D3 receptor
Nephrology
Small molecule
Live · refreshed every 30 min
Target snapshot
Calciferol (Calciferol) — Department of Medical Services Ministry of Public Health of Thailand.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Calciferol TARGET | Calciferol | Department of Medical Services Ministry of Public Health of Thailand | phase 1 | Vitamin D 25-hydroxylase, 25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial, Vitamin D3 receptor |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Calciferol CI watch — RSS
- Calciferol CI watch — Atom
- Calciferol CI watch — JSON
- Calciferol alone — RSS
Cite this brief
Drug Landscape (2026). Calciferol — Competitive Intelligence Brief. https://druglandscape.com/ci/calciferol. Accessed 2026-06-09.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing